| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |